IP Library Granted Patent US 8,303,801
Granted Patent B2
US 8,303,801 · App. 13/339,598 · Granted Nov 6, 2012

Method for determining the concentration of an analyte in a liquid sample using small volume samples and fast test times

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,303,801
App. No.
13/339,598
Granted
Nov 6, 2012
Kind
B2
Abstract

Analytes in a liquid sample are determined by methods utilizing sample volumes of less than about 1.0 μl and test times within about nine seconds. The methods are preferably performed using small test strips including a sample receiving chamber filled with the sample by capillary action.

Claims (48)

1. A method of determining the concentration of glucose in a blood sample, comprising:

providing a disposable biosensor test strip including a capillary chamber having a depth suitable for capillary flow of blood, and holding a volume of from about 0.3 μl to about 0.6 μl of the blood sample, working and counter or reference electrodes disposed within the capillary chamber, the working electrode including one or more electrically connected electrode elements having an aggregate width of about 100 μm to about 1350 μm, and a reagent proximal to or in contact with at least the working electrode, the reagent including an enzyme and a mediator;

applying a blood sample containing glucose into the capillary chamber, the capillary chamber directing capillary flow of the blood sample into contact with the reagent to cause the blood sample to at least partially solubilize or hydrate the reagent, the glucose reacting with the reagent to produce an electroactive reaction product;

detecting the blood sample in the capillary chamber;

following said detecting, providing a delay period prior to application of an electrooxidation assay potential across the working and counter or reference electrodes;

following said delay period, applying an electrooxidation assay potential across the working and counter or reference electrodes;

electrooxidizing the electroactive reaction product at the working electrode, said electrooxidizing producing an assay current;

measuring the assay current at one or more times after applying the assay potential,

correlating the assay current measurement to the concentration of glucose in the blood sample, and

within the time period lasting from about 2 to about 8 seconds after said detecting, providing a readout of the glucose concentration in the blood sample.

2. The method of claim 1 in which said providing a readout comprises providing a readout about 5 seconds after said detecting.

3. The method of claim 1 in which said providing a readout comprises providing a readout about 8 seconds after said detecting.

4. The method of claim 1 in which the delay period is about 3 seconds, and within the time period lasting from about 3 to about 8 seconds after said detecting, providing a readout of the glucose concentration in the blood sample.

5. The method of claim 1 in which said measuring comprises measuring the assay current at one or more times within the time period lasting from about 3 to about 5 seconds after said detecting, and within the time period lasting from about 3 to about 5 seconds after said detecting, providing a readout of the glucose concentration in the blood sample.

6. The method of claim 1 in which said measuring comprises measuring the assay current at one or more times up to about 2 seconds after the delay period, and at about 2 seconds after said detecting, providing a readout of the glucose concentration in the blood sample.

7. The method of claim 1 in which the delay period is about 3 seconds, and in which said measuring comprises measuring the assay current at one or more times within the time period lasting from about 3 to about 5 seconds after said detecting, and within the time period lasting from about 3 to about 5 seconds after said detecting, providing a readout of the glucose concentration in the blood sample.

8. The method of claim 1 in which the working electrode has an aggregate width of about 100 μm to about 700 μm.

9. The method of claim 8 in which the electrooxidation assay potential is a DC potential.

10. The method of claim 8 in which the delay period comprises an open circuit time during which no potential is applied across the working and counter or reference electrodes.

11. The method of claim 8 in which the capillary chamber has a depth of 100 μm to 200 μm.

12. The method of claim 8 in which the working electrode has an aggregate width of about 250 μm to about 700 μm.

13. The method of claim 1 in which the delay period comprises a delay period of about 3 seconds following said detecting, said applying comprises applying an electrooxidation assay potential across the working and counter or reference electrodes within the time period lasting from about 3 seconds to about 5 seconds following said detecting, said measuring comprises measuring the assay current within the time period lasting from about 3 seconds to about 5 seconds following said detecting, and within the time period lasting from about 3 to about 5 seconds after said detecting, providing a readout of the glucose concentration in the blood sample.

14. The method of claim 13 in which the working electrode has an aggregate width of about 100 μm to about 700 μm.

15. The method of claim 14 in which the electrooxidation assay potential is a DC potential.

16. The method of claim 14 in which the delay period comprises an open circuit time during which no potential is applied across the working and counter or reference electrodes.

17. The method of claim 14 in which the capillary chamber has a depth of 100 μm to 200 μm.

18. The method of claim 14 in which the working electrode has an aggregate width of about 100 μm to about 500 μm.

19. A method of determining the concentration of glucose in a blood sample, comprising:

providing a disposable biosensor test strip including a capillary chamber having a depth suitable for capillary flow of blood, and holding a volume of from about 0.3 μl to about 0.6 μl of the blood sample, working and counter or reference electrodes disposed within the capillary chamber, the working electrode including one or more electrically connected electrode elements having an aggregate area of 0.1 mm 2 to 1.4 mm 2 , and a reagent proximal to or in contact with at least the working electrode, the reagent including an enzyme and a mediator;

applying a blood sample containing glucose into the capillary chamber, the capillary chamber directing capillary flow of the blood sample into contact with the reagent to cause the blood sample to at least partially solubilize or hydrate the reagent, the glucose reacting with the reagent to produce an electroactive reaction product;

detecting the blood sample in the capillary chamber;

following said detecting, providing a delay period prior to application of an electrooxidation assay potential across the working and counter or reference electrodes;

following said delay period, applying an electrooxidation assay potential across the working and counter or reference electrodes;

electrooxidizing the electroactive reaction product at the working electrode, said electrooxidizing producing an assay current;

measuring the assay current at one or more times after applying the assay potential,

correlating the assay current measurement to the concentration of glucose in the blood sample, and

within the time period lasting from about 2 to about 8 seconds after said detecting, providing a readout of the glucose concentration in the blood sample.

20. The method of claim 19 in which the electrooxidation assay potential is a DC potential.

21. The method of claim 19 in which the delay period comprises an open circuit time during which no potential is applied across the working and counter or reference electrodes.

22. The method of claim 19 in which the capillary chamber has a depth of 100 μm to 200 μm.

23. The method of claim 19 in which the working electrode has an aggregate area of 0.1 mm 2 to 0.5 mm 2 .

24. The method of claim 23 in which the electrooxidation assay potential is a DC potential.

25. The method of claim 23 in which the delay period comprises an open circuit time during which no potential is applied across the working and counter or reference electrodes.

26. The method of claim 23 in which the capillary chamber has a depth of 100 μm to 200 μm.

27. The method of claim 23 in which the delay period comprises a delay period of about 3 seconds following said detecting, said applying comprises applying an electrooxidation assay potential across the working and counter or reference electrodes within the time period lasting from about 3 seconds to about 5 seconds following said detecting, said measuring comprises measuring the assay current within the time period lasting from about 3 seconds to about 5 seconds after said detecting, and within the time period lasting from about 3 to about 5 seconds after said detecting, providing a readout of the glucose concentration in the blood sample.

28. The method of claim 27 in which the electrooxidation assay potential is a DC potential.

29. The method of claim 28 in which the delay period comprises an open circuit time during which no potential is applied across the working and counter or reference electrodes.

30. The method of claim 29 in which the capillary chamber has a depth of 100 μm to 200 μm.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2024
From: ROCHE OPERATIONS LTD.
To: ROCHE DIABETES CARE, INC.
Reel/Frame 067204/0694 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2015
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: ROCHE DIABETES CARE, INC.
Reel/Frame 036008/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2012
From: WILSEY, CHRISTOPHER D., MR.
To: ROCHE DIAGNOSTICS CORPORATION
Reel/Frame 027739/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2012
From: ROCHE DIAGNOSTICS CORPORATION
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 027739/0969 →
CHANGE OF NAME Recorded Feb 22, 2012
From: CORANGE INTERNATIONAL LIMITED
To: ROCHE OPERATIONS LTD.
Reel/Frame 027739/0985 →
ASSIGNMENT OF AN UNDIVIDED ONE-HALF INTEREST Recorded Feb 22, 2012
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: CORANGE INTERNATIONAL LIMITED
Reel/Frame 027746/0795 →